<DOC>
	<DOCNO>NCT01946009</DOCNO>
	<brief_summary>Cidofovir could effective drug treatment Anal Intraepithelial Neoplasia ( AIN ) .</brief_summary>
	<brief_title>A Prospective , With One Site , Open-label Not Controled Trial , Observation Treatment With CIDOFOVIR 1 % , 3 Nights Per Week , During 4 Weeks , Anal Intraepithelial Neoplasia , High Level , HIV+ Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Cidofovir</mesh_term>
	<criteria>1 . Patients give informed consent write study make specific selection procedure study . 2 . Adult patient ( 18 year ) document HIV infection , highgrade AIN demonstrate biopsy , receive prior treatment Anal Intraepithelial Neoplasia last 12 week . 3 . For woman childbearing potential , negative pregnancy test urine screen visit . All woman childbearing age continue effective contraception throughout study treatment . 1 . Patients receive previous treatment Anal Intraepithelial Neoplasia ( AIN ) last 12 week . 2 . Dermatoses patient anogenital area 3 . Patients history preinvasive neoplasia associate Human Papilloma Virus 4 . Patients history previous neoplasm , origin location , past 5 year . 5 . Patients history hematologic abnormality , kidney liver 6 . Pregnant breastfeed woman woman childbearing age wish use adequate contraception discretion investigator . 7 . Any disease condition patient , opinion investigator , adequate patient participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>